Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-26-060337
Filing Date
2026-05-22
Accepted
2026-05-22 09:22:13
Documents
2
Period of Report
2026-05-22

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0291473-6k_regencell.htm 6-K 10553
2 PRESS RELEASE - REGENCELL BIOSCIENCE HOLDINGS LIMITED ANNOUNCES CLOSING OF REGIS ea029147301ex99-1.htm EX-99.1 9482
  Complete submission text file 0001213900-26-060337.txt   21222
Mailing Address 9/F CHINACHEM LEIGHTON PLAZA 29 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG China
Business Address 9/F CHINACHEM LEIGHTON PLAZA 29 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG China 852 2155 0823
Regencell Bioscience Holdings Ltd (Filer) CIK: 0001829667 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9
Type: 6-K | Act: 34 | File No.: 001-40617 | Film No.: 261011125
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)